On the heels of its January rebranding, 50-year old Bay Area institution HCA Houston Healthcare Clear Lake celebrates miracles and milestones

May 2nd, 2019

HCA Houston Healthcare Clear Lake CEO Todd Caliva poses outside of his newly rebranded hospital

“I’m what you’d call an HCA Lifer and have been with this company a long time. As HCA Houston Healthcare Clear Lake aligns more deeply with the broader HCA network and looks forward to major investments in women’s and emergency services, our future has never been more bright. I’m proud of our staff, patients, and community for their resilience and commitment to making the Bay Area best-in-class not just for medicine, but for working and living.”

-Todd Caliva, CEO, HCA Houston Healthcare Clear Lake


HCA Houston Healthcare Clear Lake at a Glance

HCA Houston Healthcare Clear Lake is a comprehensive community hospital, differentiated by:

  • 47 years serving Houston’s Bay Area community
  • Level II trauma center
  • High-risk obstetrical care
  • Level IIIb NICU
  • Pediatric ICU
  • Comprehensive Stroke Facility
  • Comprehensive Cancer Center
  • Only dedicated Heart Hospital South of Houston

Get in touch:

HCAhoustonhealthcare.com/clearlake
(281) 332-2511

HCA Houston Healthcare Clear Lake launches innovative alternative to open heart surgery

May 2nd, 2019

The HCA Houston Healthcare Clear Lake cardiology team celebrates after the hospital’s first TAVR procedures.

This April, Houston’s Bay Area marked a major cardiology milestone as HCA Houston Healthcare Clear Lake launched its transcatheter aortic valve replacement (TAVR) service, successfully completing three procedures on its first day.

A relatively new procedure, TAVR replaces damaged aortic valves through a catheter in contrast to open-heart surgery in which surgeons cut open the chest to expose the heart. Typically, candidates for TAVR suffer from aortic stenosis, a common but serious valve problem in which the aortic valve opening narrows, dangerously restricting blood flow and affecting pressure in the heart.

The Food and Drug Administration (FDA) approved TAVR in 2012 for patients who are considered at high risk for open-heart surgery. In 2016, the FDA approved the procedure for patients at intermediate risk. Later this year, experts expect the agency to expand its approval to low-risk patients, which will dramatically increase the number of patients who qualify for TAVR.

Just this April, Rolling Stones rocker Mick Jagger underwent TAVR for his heart valve disease, raising awareness of the procedure’s benefits, including not needing to rely on a bypass machine and a faster recovery – one to two days instead of three to five.

The FDA imposes strict requirements for hospitals wishing to practice TAVR, including successfully completing a certain number of open heart, surgical aortic valve, catheter, and percutaneous coronary interventions per year. The heart hospital at HCA Houston Healthcare Clear Lake, the only dedicated heart hospital in the Bay Area, performs more than 1,000 heart procedures annually.

Surgeons Pranav Loyalka and Hannan Chaugle worked with a team of cardiologists to successfully perform HCA Houston Healthcare Clear Lake’s first TAVR procedures. Patients interested in learning more about TAVR and other cardiology services should call (888) 842-3627 for more information.